Preferred Label : Donnai-barrow syndrome;
Symbol : DBS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Faciooculoacousticorenal syndrome; Dbs/foar syndrome; Diaphragmatic hernia, exomphalos, absent corpus callosum, hypertelorism, myopia, sensorineural
deafness, and proteinuria; FOAR;
Description : The faciooculoacousticorenal (FOAR) syndrome was first described as comprising facial
anomalies, ocular anomalies, sensorineural hearing loss, and proteinuria. Facial features
include prominent brow, short nose, and hypertelorism, and ocular anomalies include
myopia, iris hypoplasia, and/or retinal detachment (Regenbogen and Coscas, 1985).
Donnai-Barrow syndrome (DBS) was first described as a distinct disorder characterized
by diaphragmatic hernia, exomphalos, absent corpus callosum, myopia, and sensorineural
deafness. The classic distinguishing features between the 2 disorders were presence
of proteinuria and absence of diaphragmatic hernia and corpus callosum anomalies in
FOAR (Donnai and Barrow, 1993). However, early reports noted that the 2 disorders
shared many phenotypic features and may be identical (e.g., Devriendt et al., 1998).
Although there is variability in the expression of some features (e.g., agenesis of
the corpus callosum and proteinuria), the disorders are now considered to represent
the same entity (Kantarci et al., 2007).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the low density lipoprotein receptor-related protein 2 gene
(LRP2, 600073.0001);
Laboratory abnormalities : Proteinuria; Urinary excretion of retinol-binding proteins (RBP) and vitamin D-binding proteins
(DBP);
Prefixed ID : #222448;
Origin ID : 222448;
UMLS CUI : C1857277;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)